High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility study.

por Jonkhoff, A. R., Plaizier, M. A., Ossenkoppele, G. J., Teule, G. J., Huijgens, P. C.
Publicado 1995

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.

por de Bree, R., Roos, J. C., Plaizier, M. A., Quak, J. J., van Kamp, G. J., den Hollander, W., Snow, G. B., van Dongen, G. A.
Publicado 1997